Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 48
1987 45
1988 44
1989 42
1990 53
1991 53
1992 50
1993 55
1994 48
1995 58
1996 59
1997 56
1998 52
1999 57
2000 56
2001 74
2002 114
2003 142
2004 158
2005 227
2006 285
2007 321
2008 284
2009 313
2010 319
2011 369
2012 363
2013 299
2014 336
2015 464
2016 446
2017 292
2018 300
2019 322
2020 95
Text availability
Article attribute
Article type
Publication date

Search Results

4,733 results
Results by year
Filters applied: . Clear all
Page 1
Current status of immunotherapy in metastatic colorectal cancer.
Wrobel P and Ahmed S. Int J Colorectal Dis 2019 - Review. PMID 30465238
Colorectal cancer is a leading cause of cancer-related death. Despite progress in systemic therapy, most patients with metastatic colorectal cancer die of their disease. There is an unmet need for more effective treatments for patients with metastatic colorectal cancer. The current data support that colorectal tumors are immunoresponsive and a subset of patients with advanced disease achieve long term benefit with immunotherapy. ...
Colorectal cancer is a leading cause of cancer-related death. Despite progress in systemic therapy, most patients with metastatic
The coroner does not know!
Lee H, et al. Int J Colorectal Dis 2018. PMID 29926231
First-line therapies in metastatic colorectal cancer: integrating clinical benefit with the costs of drugs.
Giuliani J and Bonetti A. Int J Colorectal Dis 2018 - Review. PMID 30196427
PURPOSE: In light of the relevant expenses of pharmacological interventions, it might be interesting to make a balance between the cost of the new drugs administered and the added value represented by the improvement in progression free survival (PFS) in first-line for metastatic colorectal cancer CRC (mCRC). ...
PURPOSE: In light of the relevant expenses of pharmacological interventions, it might be interesting to make a balance between the cost of t …
Starry-sky bowels
Chang FM, et al. Int J Colorectal Dis 2018. PMID 30280253
METHODS: A dialysis patient received a plain film and a computed tomography, both showing a "starry-sky" appearance in the nearly whole colon, and the radiological report mistakenly denoted it as barium. ...
METHODS: A dialysis patient received a plain film and a computed tomography, both showing a "starry-sky" appearance in the nearly whole c
Prevalence of colorectal cancer in acute uncomplicated diverticulitis and the role of the interval colonoscopy.
Soh NYT, et al. Int J Colorectal Dis 2018. PMID 29663068
Colonoscopy and histopathology reports were reviewed for patients who underwent interval colonic evaluation. For patients who defaulted follow-up, national health records were reviewed for any subsequent diagnoses of colorectal cancer. ...One hundred and thirty-five patients (59.5%) underwent follow-up colonic evaluation. The overall prevalence of colorectal cancer was 1.8%, with half these patients presenting with acute colonic obstruction after defaulting follow-up evaluation. ...
Colonoscopy and histopathology reports were reviewed for patients who underwent interval colonic evaluation. For patients who
Frailty in surgical patients
Richards SJG, et al. Int J Colorectal Dis 2018 - Review. PMID 30218144
4,733 results
Jump to page
Feedback